During the past decade, Svendborg Sygehus conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Svendborg Sygehus" #1 sponsor was "Odense University Hospital" with 5 trials, followed by "Amgen" with 3 trials sponsored, "Naestved Hospital" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Bio-Medisinsk Innovasjon" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Svendborg Sygehus" #1 collaborator was "Svendborg Hospital" with 4 trials as a collaborator, "Vejle Hospital" with 3 trials as a collaborator, "Aalborg University Hospital" with 2 trials as a collaborator, "Aarhus University Hospital" with 2 trials as a collaborator and "Bispebjerg Hospital" with 2 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Svendborg Sygehus" are "Analgesia" (2 trials), "Cardiac Disease" (2 trials), "Cardiovascular Disease" (2 trials), "Hip Arthropathy" (2 trials) and "Pain, Acute" (2 trials). Many other conditions were trialed in "Svendborg Sygehus" in a lesser frequency.

Most popular intervention types in "Svendborg Sygehus" are "Drug" (7 trials), "Diagnostic Test" (3 trials), "Behavioral" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Evolocumab" (2 trials), "Ibuprofen" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Controlgroup, sedation with daily wake-up trial" (1 trials). Other intervention names were less common.

The vast majority of trials in "Svendborg Sygehus" are 15 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 9 active trials in "Svendborg Sygehus". 1 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Svendborg Sygehus, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Svendborg Sygehus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 9 trials that are defined as “Not Applicable".